Showing results (101-110 of 387) with videos related to

Sort By:
Pageof 39
Expert Opinion on Biological Therapy|December 1, 2001
Immunotherapeutic approaches to inflammatory bowel diseasesM H Holtmann, P R Galle, M F Neurath
Journal of Molecular Medicine (Berlin, Germany)|January 3, 2026
The role of the TIM-3 receptor in inflammatory bowel disease and autoimmunity: implications for TIM-3 and TCR crosstalkM Gabel, A Knauss, M F Neurath, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|May 15, 2014
Liver stiffness assessed by acoustic radiation force impulse (ARFI) technology is considerably increased in patients with cholestasisL Pfeifer, D Strobel, M F Neurath, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|September 16, 2015
[Toxic megacolon]M Leppkes, M Ganslmayer, R Strauß, et al.
BMC Gastroenterology|January 23, 2021
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort studyLaura Mühl, Emily Becker, Tanja M Müller, et al.
Inflammatory Bowel Diseases|December 23, 2023
Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD PatientsIsabelle Lethen, Kristina Lechner-Grimm, Michael Gabel, et al.
European Journal of Immunology|October 1, 1996
Physiological activation of the IgH 3' enhancer in B lineage cells is not blocked by Pax-5T Andersson, M F Neurath, P A Grant, et al.
Gene|February 17, 2001
Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cellsY Linderson, N S French, M F Neurath, et al.
The Journal of Experimental Medicine|April 1, 1994
The B cell-specific transcription factor BSAP regulates B cell proliferationY Wakatsuki, M F Neurath, E E Max, et al.
Pageof 39